Last reviewed · How we verify

TAP Block Group

Mayo General Hospital, Ireland · FDA-approved active Small molecule

TAP block is a regional anesthesia technique that infiltrates local anesthetic into the transversus abdominis plane to block sensory nerves supplying the abdominal wall.

TAP block is a regional anesthesia technique that infiltrates local anesthetic into the transversus abdominis plane to block sensory nerves supplying the abdominal wall. Used for Perioperative analgesia for abdominal surgery, Postoperative pain management following abdominal procedures.

At a glance

Generic nameTAP Block Group
Also known as0.25% Bupivacaine, transversus abdominis plane, abdominal muscle anesthesia, TAP, Bupivacaine 0.5%, Ropivacaine with Epinephrine
SponsorMayo General Hospital, Ireland
ModalitySmall molecule
Therapeutic areaAnesthesia/Pain Management
PhaseFDA-approved

Mechanism of action

The TAP block targets the nerves (T6-L1) that run between the internal oblique and transversus abdominis muscles of the abdominal wall. By depositing local anesthetic in this anatomical plane, the procedure provides anesthesia and analgesia to the abdominal wall without affecting visceral innervation. This technique is used perioperatively to reduce pain and opioid requirements.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: